P-glycoprotein (P-gp) is a transporter of great clinical and pharmacological significance. Several structural studies of P-gp and its homologs have provided insights into its transport cycle, but questions remain regarding how P-gp recognizes diverse substrates and how substrate binding is coupled to ATP hydrolysis. Here, four new P-gp co-crystal structures with a series of rationally designed ligands are presented. It is observed that the binding of certain ligands, including an ATP-hydrolysis stimulator, produces a large conformational change in the fourth transmembrane helix, which is positioned to potentially transmit a signal to the nucleotide-binding domains. A new ligand-binding site on the surface of P-gp facing the inner leaflet of the membrane is also described, providing vital insights regarding the entry mechanism of hydrophobic drugs and lipids into P-gp. These results represent significant advances in the understanding of how P-gp and related transporters bind and export a plethora of metabolites, antibiotics and clinically approved and pipeline drugs.
Designed β-strand peptides stabilize integral membrane proteins for biochemical and structural studies, enabling electron microscopy analysis of the dynamic conformations of the ABC transporter MsbA. We designed β-strand peptides that stabilize integral membrane proteins (IMPs). β-strand peptides self-assemble in solution as filaments and become restructured upon association with IMPs; resulting IMP–β-strand peptide complexes resisted aggregation when diluted in detergent-free buffer and were visible as stable, single particles with low detergent background in electron micrographs. β-strand peptides enabled clear visualization of flexible conformations in the highly dynamic ATP-binding cassette (ABC) transporter MsbA.
11 March 2013 in Proceedings of the National Academy of Sciences
Significance: Membrane proteins (MPs) perform a variety of essential cellular functions, account for about one-third of encoded proteins in genomes, and comprise more than one-half of human drug targets. High-resolution structures are essential to understand the underlying molecular mechanisms of MPs and facilitate structure-based drug design efforts. Detergents are indispensible in the solubilization of MPs, but they tend to destabilize MPs and often impede the growth of well-ordered protein crystals. We describe a class of structurally unique detergents, designated as facial amphiphiles, which improved MP stability and success in the crystallization of different families of MPs.
11 September 2007 in Angewandte Chemie International Edition